Acetate is the most abundant SCFA in the colon.
Comprehensive Stool Analysis / Parasitology
The Comprehensive Stool Analysis detects the presence of pathogenic microorganisms such as yeast, parasites, and bacteria that contribute to chronic illness and neurological dysfunction. It provides helpful information about prescription and natural products effective against specific strains detected in the sample. The test also evaluates beneficial bacteria levels, intestinal immune function, overall intestinal health, and inflammation markers.
Many chronic disorders come from digestive problems and inadequate nutrient absorption. Proper gastrointestinal function is needed to eliminate toxic substances, pathogenic microbes, and undigested food particles from the body to prevent health problems. Nutrients require a specific internal environment to be properly digested and transported throughout the body.
Abnormal intestinal microorganisms in the GI tract are widely known to cause disease. Research shows a relationship between the GI tract and the neurological, hepatic, and immune systems. For example, excessive yeast produces toxic substances that can pass through the blood-brain barrier and alter neurological functioning causing “brain fog,” behavior problems, and learning difficulties.
Why Conduct a Comprehensive Stool Analysis?
The Comprehensive Stool Analysis + Parasitology (CSAP) is an essential diagnostic tool that enables practitioners to assess the status of beneficial and imbalanced commensal bacteria, pathogenic bacteria, yeast/fungus, and parasites. The identification of pathogenic species and susceptibility testing assists in the selection of the most suitable pharmaceutical or natural treatment agents.
The Comprehensive Stool Analysis test measures:
- Digestion and absorption of nutrients (Pancreatic Elastase, Muscle Fibers, and Vegetable Fibers)
- Elimination efficiency of undigested food residues and toxins
- Assessment of the gut microbiome, measuring levels of healthy bacterial flora versus potentially pathogenic bacteria species, yeast, and parasites
- Culture and sensitivities of pathogenic yeast and bacteria
- Infectious pathogens (EIA evaluation for Campylobacter, Enterohemorrhagic E. coli cytotoxin, Giardia lamblia, and Cryptosporidium)
- Indices and markers of intestinal immune function (Secretory IgA)
- Indices and markers of inflammation (Calprotectin, Lactoferrin, and Lysozyme)
- Indices and markers of intestinal physiology and of intestinal health (Presence of RBC, WBC, Mucus, Occult Blood, Fecal pH, and Short Chain Fatty Acids)
Efficient remediation of GI dysfunctions involves a comprehensive approach that includes elimination of pathogens and irritants, supplementation of hydrochloric acid, pancreatic enzymes, and pre- and probiotics, and repair of the mucosal barrier.
Biomarkers in this category
13 biomarkers · optimal ranges shown
Short-chain fatty acid
produced as a result of the fermentation of dietary fiber.
Calprotectin is a protein that binds to both calcium and zinc.
Pancreatic insufficiency test
a protein released by a type of white blood cell called a neutrophil.
to gauge inflammatory activity in IBD patients
Fecal pH
a short-chain fatty acid.
Immune Response
Acetate, n-Butyrate, Propionate
Short Chain Fatty Acid
Yeast identification on a Comprehensive Stool Analysis is a critical aspect of gastrointestinal health assessments, offering valuable insights into the microbial balance within the digestive system. This analysis plays a pivotal role in identifying the presence and overgrowth of yeast species, such as Candida, which can significantly impact gut health and overall well-being. In a balanced gut microbiome, yeast exists harmlessly along with various beneficial bacteria, but factors like antibiotic use, diet, and stress can disrupt this balance, leading to yeast overgrowth. Symptoms of yeast overgrowth can include gastrointestinal discomfort, bloating, fatigue, and can even affect mental health. The Comprehensive Stool Analysis not only detects the presence of yeast but can also provide quantitative data on its concentration, helping to discern between normal colonization and problematic overgrowth. This is crucial for the diagnosis and management of conditions like candidiasis. Additionally, the analysis can identify specific yeast strains, which is vital for tailoring treatment strategies, especially in cases resistant to standard therapies. This stool test is a key tool in functional medicine, enabling healthcare providers to diagnose, manage, and monitor conditions related to yeast overgrowth. It highlights the importance of understanding the gut microbiome's complex ecosystem and its impact on health and disease. The inclusion of yeast analysis in stool tests reflects the growing recognition of gut health's significance in overall health and the need for comprehensive diagnostic approaches in gastrointestinal health care.